NASDAQ Composite opens in less than one hour and Pacific Biosciences of California‘s pre-market value is already 7.41% down.

The last session, NASDAQ Composite finished with Pacific Biosciences of California sliding 0.45% to $33.48. NASDAQ Composite rose 0.22% to $14,082.55, following the last session’s upward trend on what was a somewhat positive trend trading session.

Pacific Biosciences of California’s last close was $33.63, 60.36% under its 52-week high of $53.69.

Pacific Biosciences of California’s Sales

Pacific Biosciences of California’s sales growth is 64% for the present quarter and 73.2% for the next. The company’s growth estimates for the present quarter and the next is a negative 4700% and a negative 26.7%, respectively.


Pacific Biosciences of California’s last day, last week, and last month’s current volatility was 0.03%, 2.18%, and 3.90%, respectively.

Pacific Biosciences of California’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 5.91% (day), 5.80% (last week), and 7.41% (last month), respectively.

More news about Pacific Biosciences of California.


Please enter your comment!
Please enter your name here